Follow up Study of Patients Having Participated in Clinical Trial 64,185-204

Clinical trial NCT02000830 · COMPLETED

Trial details

NCT number: NCT02000830
Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Status: COMPLETED
Study type: OBSERVATIONAL

Hyperbilirubinemia, Neonatal

Start date: 2013-10-17
Primary completion: 2020-02-28
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.